First Trust Amex Biotech Index Fund (FBT) Declined -5.3% or -7.69 To Price $137.52 On Wednesday


First Trust Amex Biotech Index Fund (FBT) declined -5.3% or -7.69 to $137.52. It is about 286301 shares traded, which is 188.35% compare to the average total volume 152007. The market cap of FBT is $2.88 billion. The year to date change is 11.75%. The 52 week price range is from $113.43 to $159.85. Price of FBT have changed -5.20% during last week. It have changed -3.95% over last month, 2.85% over last 3 months, -2.71% over last 6 months and 7.19% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for FBT is 147.91. It is 7.56% above current price. The 200-day Moving Averages for FBT is 144.51. It is 5.08% above current price. The 52-week High is 159.85. It is 16.24% from the current price. The 52-week Low is 113.43. It is -17.52% from current price.

There are some statistics of FBT. It is has market cap $2.88 billion. The share outstanding is 20.95 million. The average volume is 152007. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of FBT is 7.13%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of FBT is -2.68%.


Tags:

Share this post